USC researcher Karolina Charaziak, PhD, has been awarded a $3.3 million National Institutes of Health (NIH) Research Project ...

ASX healthcare shares surged 21% over the past month. Can CSL, ResMed, and Cochlear keep climbing into the future?

Summer is a season for social events, backyard barbecues, family vacations, and long conversations with friends. But for the ...

Cochlear shares remain under pressure following a significant earnings downgrade and weaker procedure volumes. Delayed surgeries and softer referral activity have weighed on demand across key markets.

One of the most dramatic single-stock moments I can recall on the ASX occurred yesterday. It revolved around ASX 200 blue chip share, healthcare stock, and hearing-loss pioneer Cochlear Ltd (ASX: COH) ...

Cochlear’s chief executive Dig Howitt has alarmed investors with a shock earnings downgrade only two months after the hearing devices giant had published its forecast profit, blaming soft sales for ...

The U.S. Food and Drug Administration has approved an expanded indication for MED-EL (Medical Electronics) cochlear implants for children ages 7 months and older with bilateral sensorineural hearing ...

Ben Summers lights up with a smile the moment he talks about the “Batman” theme song or the afternoons he spends playing the piano at his grandmother’s house. Just a few years ago, Ben could not hear ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Abstract: Auditory evoked potentials are of great interest to objectively evaluate the audition in cochlear implant (CI) recipients. However, these measures are impeded by CI stimulation electrical ...

Upgradeable Firmware: The Cochlear™ Nucleus® Nexa™ System features upgradeable firmware on the implant – an industry first, allowing recipients to access future innovation through firmware updates.